IN2013MU03426A - - Google Patents
Info
- Publication number
- IN2013MU03426A IN2013MU03426A IN3426MU2013A IN2013MU03426A IN 2013MU03426 A IN2013MU03426 A IN 2013MU03426A IN 3426MU2013 A IN3426MU2013 A IN 3426MU2013A IN 2013MU03426 A IN2013MU03426 A IN 2013MU03426A
- Authority
- IN
- India
- Prior art keywords
- release composition
- relates
- modified
- oxcarbazepine
- salts
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a solid oral modified-release composition comprising oxcarbazepine or salts thereof. In particular, the present invention relates to a solid oral modified-release composition comprising matrix of oxcarbazepine or salts thereof with one or more pharmaceutically acceptable excipients; wherein the composition is devoid of excipients having pH-dependent solubility. The invention further relates to a process of preparing such modified-release composition and its use in treatment of epileptic seizures.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3426MU2013 IN2013MU03426A (en) | 2013-10-30 | 2013-10-30 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3426MU2013 IN2013MU03426A (en) | 2013-10-30 | 2013-10-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU03426A true IN2013MU03426A (en) | 2015-07-31 |
Family
ID=54397480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3426MU2013 IN2013MU03426A (en) | 2013-10-30 | 2013-10-30 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN2013MU03426A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11980622B1 (en) | 2020-06-17 | 2024-05-14 | Apotex Inc. | Oxcarbazepine extended release dosage form |
-
2013
- 2013-10-30 IN IN3426MU2013 patent/IN2013MU03426A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11980622B1 (en) | 2020-06-17 | 2024-05-14 | Apotex Inc. | Oxcarbazepine extended release dosage form |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017502297A1 (en) | Antibacterial compounds | |
IN2015DN01156A (en) | ||
MX2015018048A (en) | Substituted benzofuranyl and benzoxazolyl compounds and uses thereof. | |
CA2900335C (en) | Synthetic analogs of epipolythiodioxopiperazines and uses thereof | |
MX364486B (en) | Pyridazinone-amides derivatives. | |
UA118380C2 (en) | Substituted dihydroisoquinolinone compounds | |
PH12016501122A1 (en) | Delayed release compositions of linaclotide | |
IN2015KN00262A (en) | ||
MX2021001169A (en) | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino}acetic acid, compositions, and uses thereof. | |
NZ727304A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
IN2014DN06966A (en) | ||
UA117032C2 (en) | A selective inhibitor of phosphatidylinositol 3-kinase-gamma | |
EA032271B9 (en) | Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases | |
EA201992832A1 (en) | SCREAM INTRODUCTION ADAMTS13 | |
IN2013MU01985A (en) | ||
MD20160111A2 (en) | Cycloalkyl-linked diheterocycle derivatives | |
MX2019000677A (en) | B-cell-mimetic cells. | |
PH12015500399A1 (en) | Azaindolines | |
IN2013MU01111A (en) | ||
MX2015007945A (en) | Uses and methods for the treatment of liver diseases or conditions. | |
MX366309B (en) | Pharmaceutical composition for treating inflammation and pain. | |
MX2018001684A (en) | Method of wound healing. | |
MX2020006075A (en) | Bendamustine pharmaceutical compositions. | |
IN2013MU03426A (en) | ||
MX2011012233A (en) | Topical retinoid solutions. |